Verticals / Pharma, medtech & health distribution / Zhejiang Taimei Medical Technology
ZT
Zhejiang Taimei Medical Technology
—
Latest disclosed NPS
no score published
0
NPS entries
0 with a number
2024
Years covered
1 entries in all
In their words
“Pre-IPO Zhejiang Taimei Medical Technology faces uncertain future due to declining customer retention rate and rejected IPO.”
NPS disclosures (0)
No NPS disclosures yet.
Retention disclosures (1)
23 Sep 2024
Retentiondown
Pre-IPO Zhejiang Taimei Medical Technology faces uncertain future due to declining customer retention rate and rejected IPO.
— reported by smartkarma.com · 23 Sep 2024 · NI-7883567
smartkarma.com ↗Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.